Abstract 651: An in Vitro Model to Test Possible Adverse Effects of Electrical Devices on ICD Function
Devices such as capsules swallowed to perform video endoscopy (VE-CAP) or cell phones equipped with Bluetooth® (BLUE) emit electrical signals which could have adverse effects on implantable cardiac defibrillators (ICDs). We sought to study whether signals from VE-CAP or BLUE could cause spurious inhibition of ventricular pacing (VPi) or spurious detection of ventricular fibrillation (VFd) in an in vitro model. A Medtronic D154ATG single chamber ICD was attached to a Medtronic 6948 lead and placed in a saline bath. The ICD was programmed to perform VVI pacing at 60 beats per minute (bpm) and to detect ventricular fibrillation as rates in excess of 188 bpm, with sensitivity programmed at 0.15 mV. ICD therapies were programmed off. A VE-CAP was placed in the saline bath 1 cm. and 6 cm. from the lead tip (LEAD) and then 1 cm. and 6 cm. from the ICD pulse generator (CAN). Marker channels recorded by wireless telemetry from the ICD were used to determine whether the VE-CAP caused interaction (+) or no interaction (−). BLUE was tested in similar fashion. Radiofrequency (RF) electocautery from a Bovie, which is known to result in VPi and VFd, was applied to the saline bath 1 and 6 cm from the lead and 1 and 6 cm from the pulse generator as a control. The results were as follows: ICD lead tips in the right ventricular apex overlie the diaphragm and are often within 1 cm of the transverse colon. However, even at this distance, interaction between a VE-CAP and an ICD resulting in VPi or VFd is unlikely to occur. Capsule video endoscopy in patients with ICDs should be safe, even in patients who are pacemaker dependent. Similarly, BLUE is unlikely to cause VPi or VFd, and should be safe in such patients.